Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients. / Sommer, Julijana le; Low, Ann Marie; Jepsen, Jens Richardt Møllegaard; Fagerlund, Birgitte; Vangkilde, Signe; Habekost, Thomas; Glenthøj, Birte; Oranje, Bob.

I: European Neuropsychopharmacology, Bind 46, 2021, s. 83-92.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sommer, JL, Low, AM, Jepsen, JRM, Fagerlund, B, Vangkilde, S, Habekost, T, Glenthøj, B & Oranje, B 2021, 'Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients', European Neuropsychopharmacology, bind 46, s. 83-92. https://doi.org/10.1016/j.euroneuro.2021.02.004

APA

Sommer, J. L., Low, A. M., Jepsen, J. R. M., Fagerlund, B., Vangkilde, S., Habekost, T., Glenthøj, B., & Oranje, B. (2021). Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients. European Neuropsychopharmacology, 46, 83-92. https://doi.org/10.1016/j.euroneuro.2021.02.004

Vancouver

Sommer JL, Low AM, Jepsen JRM, Fagerlund B, Vangkilde S, Habekost T o.a. Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients. European Neuropsychopharmacology. 2021;46:83-92. https://doi.org/10.1016/j.euroneuro.2021.02.004

Author

Sommer, Julijana le ; Low, Ann Marie ; Jepsen, Jens Richardt Møllegaard ; Fagerlund, Birgitte ; Vangkilde, Signe ; Habekost, Thomas ; Glenthøj, Birte ; Oranje, Bob. / Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients. I: European Neuropsychopharmacology. 2021 ; Bind 46. s. 83-92.

Bibtex

@article{04efb3945b6d4404aeaffd24fa860c67,
title = "Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-na{\"i}ve adult ADHD patients",
abstract = "Deficient information processing in ADHD theoretically results in sensory overload, which in turn may underlie its symptoms. If this sensory overload is caused by deficient filtering of environmental stimuli, then one would expect finding deficits in P50 gating and prepulse inhibition of the startle reflex (PPI). Previous reports on these measures in ADHD have shown inconsistent findings, which may have been caused by either medication use or comorbidity (e.g. ASD). The primary aim of this study was therefore to explore P50 suppression and PPI in adult, psychostimulant-na{\"i}ve patients with ADHD without major comorbidity, and to examine the effects of 6 weeks treatment with methylphenidate (MPH) on these measures. A total of 42 initially psychostimulant-naive, adult ADHD patients without major comorbidity and 42 matched healthy controls, were assessed for their P50 gating, PPI, and habituation/sensitization abilities at baseline and after 6 weeks of treatment with methylphenidate. Although six weeks of treatment with MPH significantly reduced symptomatology as well as improved daily life functioning in our patients, it neither significantly affected PPI, P50 suppression nor sensitization, but habituation unexpectedly decreased. The absence of PPI and P50 suppression deficits in our patients in the psychostimulant-na{\"i}ve state indicates no gating deficits. In turn, this suggests that the difficulties to inhibit distraction of attention by irrelevant stimuli that many patients with (adult) ADHD report, have a different origin than the theoretical causes of sensory overload frequently reported in studies on patients with schizophrenia.",
keywords = "Adult ADHD, Endophenotypes, Methylphenidate, Sensorimotor gating, Sensory gating",
author = "Sommer, {Julijana le} and Low, {Ann Marie} and Jepsen, {Jens Richardt M{\o}llegaard} and Birgitte Fagerlund and Signe Vangkilde and Thomas Habekost and Birte Glenth{\o}j and Bob Oranje",
year = "2021",
doi = "10.1016/j.euroneuro.2021.02.004",
language = "English",
volume = "46",
pages = "83--92",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients

AU - Sommer, Julijana le

AU - Low, Ann Marie

AU - Jepsen, Jens Richardt Møllegaard

AU - Fagerlund, Birgitte

AU - Vangkilde, Signe

AU - Habekost, Thomas

AU - Glenthøj, Birte

AU - Oranje, Bob

PY - 2021

Y1 - 2021

N2 - Deficient information processing in ADHD theoretically results in sensory overload, which in turn may underlie its symptoms. If this sensory overload is caused by deficient filtering of environmental stimuli, then one would expect finding deficits in P50 gating and prepulse inhibition of the startle reflex (PPI). Previous reports on these measures in ADHD have shown inconsistent findings, which may have been caused by either medication use or comorbidity (e.g. ASD). The primary aim of this study was therefore to explore P50 suppression and PPI in adult, psychostimulant-naïve patients with ADHD without major comorbidity, and to examine the effects of 6 weeks treatment with methylphenidate (MPH) on these measures. A total of 42 initially psychostimulant-naive, adult ADHD patients without major comorbidity and 42 matched healthy controls, were assessed for their P50 gating, PPI, and habituation/sensitization abilities at baseline and after 6 weeks of treatment with methylphenidate. Although six weeks of treatment with MPH significantly reduced symptomatology as well as improved daily life functioning in our patients, it neither significantly affected PPI, P50 suppression nor sensitization, but habituation unexpectedly decreased. The absence of PPI and P50 suppression deficits in our patients in the psychostimulant-naïve state indicates no gating deficits. In turn, this suggests that the difficulties to inhibit distraction of attention by irrelevant stimuli that many patients with (adult) ADHD report, have a different origin than the theoretical causes of sensory overload frequently reported in studies on patients with schizophrenia.

AB - Deficient information processing in ADHD theoretically results in sensory overload, which in turn may underlie its symptoms. If this sensory overload is caused by deficient filtering of environmental stimuli, then one would expect finding deficits in P50 gating and prepulse inhibition of the startle reflex (PPI). Previous reports on these measures in ADHD have shown inconsistent findings, which may have been caused by either medication use or comorbidity (e.g. ASD). The primary aim of this study was therefore to explore P50 suppression and PPI in adult, psychostimulant-naïve patients with ADHD without major comorbidity, and to examine the effects of 6 weeks treatment with methylphenidate (MPH) on these measures. A total of 42 initially psychostimulant-naive, adult ADHD patients without major comorbidity and 42 matched healthy controls, were assessed for their P50 gating, PPI, and habituation/sensitization abilities at baseline and after 6 weeks of treatment with methylphenidate. Although six weeks of treatment with MPH significantly reduced symptomatology as well as improved daily life functioning in our patients, it neither significantly affected PPI, P50 suppression nor sensitization, but habituation unexpectedly decreased. The absence of PPI and P50 suppression deficits in our patients in the psychostimulant-naïve state indicates no gating deficits. In turn, this suggests that the difficulties to inhibit distraction of attention by irrelevant stimuli that many patients with (adult) ADHD report, have a different origin than the theoretical causes of sensory overload frequently reported in studies on patients with schizophrenia.

KW - Adult ADHD

KW - Endophenotypes

KW - Methylphenidate

KW - Sensorimotor gating

KW - Sensory gating

U2 - 10.1016/j.euroneuro.2021.02.004

DO - 10.1016/j.euroneuro.2021.02.004

M3 - Journal article

C2 - 33663902

AN - SCOPUS:85101872975

VL - 46

SP - 83

EP - 92

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

ER -

ID: 259053546